News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CureDuchenne, AVI BioPharma, Inc. (AVII), And ProSensa B.V. Exon Skipping Hosting Conference for Duchenne Muscular Dystrophy



10/14/2008 10:19:01 AM

CORONA DEL MAR, Calif.--(BUSINESS WIRE)--The Foundation to Eradicate Duchenne (FED), the CureDuchenne Foundation, AVI BioPharma and Prosensa will host an Exon Skipping Conference for Duchenne Muscular Dystrophy from October 14 -17, 2008 at the Banbury Center of Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. Participants are being drawn from a wide area of research, from chemistry to regulatory authorities, to critically review progress on oligonucleotides as therapeutic agents for Duchenne Muscular Dystrophy.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES